Product Details for NDA 018132
DOPAMINE HYDROCHLORIDE (DOPAMINE HYDROCHLORIDE)
40MG/ML
Marketing Status: Prescription
80MG/100ML
Marketing Status: Prescription
80MG/ML
Marketing Status: Prescription
160MG/100ML
Marketing Status: Prescription
40MG/ML
Marketing Status: Prescription
Active Ingredient: DOPAMINE HYDROCHLORIDE
Proprietary Name: DOPAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N018132
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
DOPAMINE HYDROCHLORIDE (DOPAMINE HYDROCHLORIDE)
Proprietary Name: DOPAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N018132
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
80MG/100ML
Marketing Status: Prescription
Active Ingredient: DOPAMINE HYDROCHLORIDE
Proprietary Name: DOPAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 80MG/100ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N018132
Product Number: 002
Approval Date: Feb 4, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
DOPAMINE HYDROCHLORIDE (DOPAMINE HYDROCHLORIDE)
Proprietary Name: DOPAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 80MG/100ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N018132
Product Number: 002
Approval Date: Feb 4, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
80MG/ML
Marketing Status: Prescription
Active Ingredient: DOPAMINE HYDROCHLORIDE
Proprietary Name: DOPAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 80MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N018132
Product Number: 004
Approval Date: Jul 9, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
DOPAMINE HYDROCHLORIDE (DOPAMINE HYDROCHLORIDE)
Proprietary Name: DOPAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 80MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N018132
Product Number: 004
Approval Date: Jul 9, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
160MG/100ML
Marketing Status: Prescription
Active Ingredient: DOPAMINE HYDROCHLORIDE
Proprietary Name: DOPAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 160MG/100ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N018132
Product Number: 003
Approval Date: Feb 4, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: DOPAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 160MG/100ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N018132
Product Number: 003
Approval Date: Feb 4, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information